Vaccine to protect seniors from RSV ready for FDA review, drugmaker says
By
Alicia Lasek (f3)
Jun 13, 2022
A vaccine to help prevent a leading cause of pneumonia in the elderly has been found effective in late-stage clinical trials.
GlaxoSmithKline plans Shingrix push; new RSV shot for elders in works
By
Alicia Lasek
Jun 28, 2021
GSK’s shingles vaccine will get a renewed marketing push following a large drop in sales during the pandemic, and the company is aiming to launch a fast-tracked shot for a common respiratory virus...
Adult immunizations fell dramatically during pandemic, vaccine maker says
By
Alicia Lasek
Jun 14, 2021
In total, 17.2 million adult vaccine doses were missed in 2020. And immunizations continue to lag well behind 2019 levels, reports GlaxoSmithKline.
Clinical Briefs for Thursday, January 23
By
Alicia Lasek
Jan 22, 2020
Use of opioids a balancing act when treating pain in residents with Alzheimer’s … GSK halts nationwide production of 2 Excedrin drugs … Drug combo reverses arthritis in rats … Discovery may lead...
Drug company to pay $3 billion to settle criminal charges
Jul 02, 2012
In what is the biggest healthcare fraud settlement in U.S. history, drugmaker GlaxoSmithKline will pay $3 billion and plead guilty to illegally promoting prescription drugs.